These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24939586)

  • 1. Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome.
    Vissers LE; Bonetti M; Paardekooper Overman J; Nillesen WM; Frints SG; de Ligt J; Zampino G; Justino A; Machado JC; Schepens M; Brunner HG; Veltman JA; Scheffer H; Gros P; Costa JL; Tartaglia M; van der Burgt I; Yntema HG; den Hertog J
    Eur J Hum Genet; 2015 Mar; 23(3):317-24. PubMed ID: 24939586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of A2ML1 variants in Noonan syndrome has to be reconsidered.
    Brinkmann J; Lissewski C; Pinna V; Vial Y; Pantaleoni F; Lepri F; Daniele P; Burnyte B; Cuturilo G; Fauth C; Gezdirici A; Kotzot D; Güleç EY; Iotova V; Schanze D; Ramond F; Havlovicová M; Utine GE; Simsek-Kiper PO; Stoyanova M; Verloes A; De Luca A; Tartaglia M; Cavé H; Zenker M
    Eur J Hum Genet; 2021 Mar; 29(3):524-527. PubMed ID: 33082526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome.
    Cordeddu V; Yin JC; Gunnarsson C; Virtanen C; Drunat S; Lepri F; De Luca A; Rossi C; Ciolfi A; Pugh TJ; Bruselles A; Priest JR; Pennacchio LA; Lu Z; Danesh A; Quevedo R; Hamid A; Martinelli S; Pantaleoni F; Gnazzo M; Daniele P; Lissewski C; Bocchinfuso G; Stella L; Odent S; Philip N; Faivre L; Vlckova M; Seemanova E; Digilio C; Zenker M; Zampino G; Verloes A; Dallapiccola B; Roberts AE; Cavé H; Gelb BD; Neel BG; Tartaglia M
    Hum Mutat; 2015 Nov; 36(11):1080-7. PubMed ID: 26173643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.
    Niihori T; Nagai K; Fujita A; Ohashi H; Okamoto N; Okada S; Harada A; Kihara H; Arbogast T; Funayama R; Shirota M; Nakayama K; Abe T; Inoue SI; Tsai IC; Matsumoto N; Davis EE; Katsanis N; Aoki Y
    Am J Hum Genet; 2019 Jun; 104(6):1233-1240. PubMed ID: 31130285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.
    Leung GKC; Luk HM; Tang VHM; Gao WW; Mak CCY; Yu MHC; Wong WL; Chu YWY; Yang WL; Wong WHS; Ma ACH; Leung AYH; Jin DY; Chan KYK; Allanson J; Lo IFM; Chung BHY
    Sci Rep; 2018 Feb; 8(1):2421. PubMed ID: 29402968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digenic inheritance of subclinical variants in Noonan Syndrome patients: an alternative pathogenic model?
    Ferrari L; Mangano E; Bonati MT; Monterosso I; Capitanio D; Chiappori F; Brambilla I; Gelfi C; Battaglia C; Bordoni R; Riva P
    Eur J Hum Genet; 2020 Oct; 28(10):1432-1445. PubMed ID: 32514133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation-a review of the literature.
    Nemcikova M; Vejvalkova S; Fencl F; Sukova M; Krepelova A
    Eur J Pediatr; 2016 Apr; 175(4):587-92. PubMed ID: 26518681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in NRAS in familial Noonan syndrome--case report and review of the literature.
    Ekvall S; Wilbe M; Dahlgren J; Legius E; van Haeringen A; Westphal O; Annerén G; Bondeson ML
    BMC Med Genet; 2015 Oct; 16():95. PubMed ID: 26467218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype.
    Martinelli S; De Luca A; Stellacci E; Rossi C; Checquolo S; Lepri F; Caputo V; Silvano M; Buscherini F; Consoli F; Ferrara G; Digilio MC; Cavaliere ML; van Hagen JM; Zampino G; van der Burgt I; Ferrero GB; Mazzanti L; Screpanti I; Yntema HG; Nillesen WM; Savarirayan R; Zenker M; Dallapiccola B; Gelb BD; Tartaglia M
    Am J Hum Genet; 2010 Aug; 87(2):250-7. PubMed ID: 20619386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing identifies rare variants associated with Noonan syndrome.
    Chen PC; Yin J; Yu HW; Yuan T; Fernandez M; Yung CK; Trinh QM; Peltekova VD; Reid JG; Tworog-Dube E; Morgan MB; Muzny DM; Stein L; McPherson JD; Roberts AE; Gibbs RA; Neel BG; Kucherlapati R
    Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11473-8. PubMed ID: 25049390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.
    Ekvall S; Hagenäs L; Allanson J; Annerén G; Bondeson ML
    Am J Med Genet A; 2011 Jun; 155A(6):1217-24. PubMed ID: 21548061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome.
    Tartaglia M; Cordeddu V; Chang H; Shaw A; Kalidas K; Crosby A; Patton MA; Sorcini M; van der Burgt I; Jeffery S; Gelb BD
    Am J Hum Genet; 2004 Sep; 75(3):492-7. PubMed ID: 15248152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
    Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
    BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome.
    Pagnamenta AT; Kaisaki PJ; Bennett F; Burkitt-Wright E; Martin HC; Ferla MP; Taylor JM; Gompertz L; Lahiri N; Tatton-Brown K; Newbury-Ecob R; Henderson A; Joss S; Weber A; Carmichael J; Turnpenny PD; McKee S; Forzano F; Ashraf T; Bradbury K; Shears D; Kini U; de Burca A; ; Blair E; Taylor JC; Stewart H
    Clin Genet; 2019 Jun; 95(6):693-703. PubMed ID: 30859559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.
    Yamamoto GL; Aguena M; Gos M; Hung C; Pilch J; Fahiminiya S; Abramowicz A; Cristian I; Buscarilli M; Naslavsky MS; Malaquias AC; Zatz M; Bodamer O; Majewski J; Jorge AA; Pereira AC; Kim CA; Passos-Bueno MR; Bertola DR
    J Med Genet; 2015 Jun; 52(6):413-21. PubMed ID: 25795793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craniosynostosis and Noonan syndrome with KRAS mutations: Expanding the phenotype with a case report and review of the literature.
    Addissie YA; Kotecha U; Hart RA; Martinez AF; Kruszka P; Muenke M
    Am J Med Genet A; 2015 Nov; 167A(11):2657-63. PubMed ID: 26249544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel KRAS mutation identified in Noonan syndrome.
    Razzaque MA; Komoike Y; Nishizawa T; Inai K; Furutani M; Higashinakagawa T; Matsuoka R
    Am J Med Genet A; 2012 Mar; 158A(3):524-32. PubMed ID: 22302539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noonan syndrome gain-of-function mutations in NRAS cause zebrafish gastrulation defects.
    Runtuwene V; van Eekelen M; Overvoorde J; Rehmann H; Yntema HG; Nillesen WM; van Haeringen A; van der Burgt I; Burgering B; den Hertog J
    Dis Model Mech; 2011 May; 4(3):393-9. PubMed ID: 21263000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.
    Tartaglia M; Kalidas K; Shaw A; Song X; Musat DL; van der Burgt I; Brunner HG; Bertola DR; Crosby A; Ion A; Kucherlapati RS; Jeffery S; Patton MA; Gelb BD
    Am J Hum Genet; 2002 Jun; 70(6):1555-63. PubMed ID: 11992261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mutation in the C-SH2 domain of PTPN11 causes Noonan syndrome with multiple giant cell lesions.
    Carapito R; Paul N; Untrau M; Ott L; Corradini N; Poignant S; Geffroy L; Caldagues E; Heymann MF; Cassagnau E; Isidor B; Bahram S
    J Hum Genet; 2014 Jan; 59(1):57-9. PubMed ID: 24225993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.